Age and IgG2 deficiency associated with zonisamide therapy: A case report

Epilepsia

Volumn 38, Issue 5, 1997, Pages 611-613

  Maeoka, Yukinori ^a   Hara, Toshiro ^a   Dejima, Sunao ^a   Takeshita, Kenzo ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Epilepsy; IgA deficiency; IgG subclass; Phenytoin; Zonisamide

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2; ZONISAMIDE; ANTICONVULSIVE AGENT; IMMUNOGLOBULIN G; ISOXAZOLE DERIVATIVE;

ARTICLE; CASE REPORT; CHILD; DISEASE COURSE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; MALE; PRIORITY JOURNAL; BLOOD; CHEMICALLY INDUCED DISORDER; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; INFANT;

ANTICONVULSANTS; EPILEPSY; HUMANS; IGA DEFICIENCY; IGG DEFICIENCY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; ISOXAZOLES; MALE;

EID: 0030610110     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1997.tb01147.x     Document Type: Article

References (15)

1. Seager J, Jameson DL. Wilson J, Hayward AR, Soothill JP. IgA deficiency, epilepsy and phenytoin treatment. Lancet 1975;2:632-5.
2. Stanworth DR, Johns P, Williamson N, Shadforth M, Felex-Davis DD, Thompson R. Drug induced IgA deficiency in rheumatoid arthritis. Lancet 1977;1:1001-2.
3. Leickly FE, Buckley RH. Development of IgA and IgG2 subclass deficiency after sulfasalazine therapy. J Pediatr 1986;108:481-2.
4. Ishizaka A, Nakanishi M, Kasahara E, Mizutani K, Sakiyama Y, Matsumoto S. Phenytoin-induced IgG2 and IgG4 deficiencies in a patient with epilepsy. Acta Paediatr 1992;81:646-8.
5. Seki T, Kumagai N. Concerning zonisamide. In: Yagi K, Seki T, eds. Zonisamide in epilepsy therapy. Tokyo: Sozo Shuppan, 1994:13-24.
6. Fujita N, Yamamori H, Yamasaki H, et al. Effect of zonisamide on serum immunoglobulin concentrations. [Abstract]. No To Hattatsu 1994;26(suppl):S212.
7. Hayashibara H, Tanimoto K, Nagata I, Harada Y, Shiraki K. Normal levels of IgG subclass in childhood determined by a sensitive ELISA. Acta Paediatr Jpn 1993;35:113-7.
8. Killingsworth LM, Savory J. Automated immunochemical procedures for measurement of immunoglobulins IgG, IgA and IgM in human serum. Clin Chem 1971;17:936-40.
9. Shida K, Hara T, Mori Y, et al. Immune thrombocytopenic purpura in an IgA-, IgG2- and IgG4-deficient child with severe atopic dermatitis. Im J Pediatr Hematol Oncol 1996;3:191-3.
10. Peters DH, Sorkin EM. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs 1993;45:760-87.
11. Fujimoto Y, Ikoma R, Shimizu T, Shimizu A. Effect of zonisamide on serum immunoglobulins. Drug Res 1990;40:855-8.
12. Gihus NE, Lea T. Carbamazepine: effect on IgG subclasses in epileptic patients. Epilepsia 1988;29:317-20.
13. Fontana A, Joller H, Skvaril F, Grob P. Immunological ab- normalities and HLA antigen frequencies in IgA deficient patients with epilepsy. J Neurol Neurosurg Psychiatry 1978;41:593-7.
14. Gihus NE, Lea T. IgG subclasses in epileptic patients treated with phenytoin. J Neurol 1989;236:149-52.
15. Guerra IC, Fawcett WA IV, Redmon AH, Lawrence EC, Rosenblatt HM, Shearer WT. Permanent intrinsic B cell immunodeficiency caused by phenytoin hypersensitivity. J Allerg Clin Immunol 1986;77:603-7.